openPR Logo
Press release

Agricultural Adjuvants Market Drivers, Restraints, Opportunities & Challenges

11-16-2021 06:46 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Markets and Markets

The global agricultural adjuvants market size is estimated to account for a value of USD 3.1 billion in 2020 and is projected to grow at a CAGR of 6.1% from 2020, to reach a value of USD 4.4 billion by 2026. The increasing need for green adjuvants, improving efficiency, and effectiveness of agrochemicals are some of the factors driving the growth of the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1240

Driver: Increased demand for green adjuvant, with an increasing focus on health and consumption of organically produced food during the Coronavirus outbreak.

In recent years, companies have been developing eco-friendly bio-based adjuvants such as methylated seed oil (MSO), modified vegetable oils, and organo-modified siloxanes. These biologically derived adjuvants are considered environment-friendly due to their high level of safety and biodegradability. In the time of the COVID outbreak, the world population is showing a trend towards higher demand for organically produced foods. There is a lot of concern rising for hygienic, healthy, and nutritious food in the markets, with people concerned about health amid the virus outbreak. Thus the demand for green and organic adjuvants is seen to remain stable in the pandemic times to increase to organic farm produce.

Restraint: Stringent regulations to manufacture adjuvants

Adjuvants produced from petrochemicals undergo various chemical processes that release toxic wastes and gases. Various regulations are imposed by government agencies such as the United States Environmental Protection Agency (US EPA) and the EU’s Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) to address them. These agencies map and monitor the toxicity emission levels within permissible levels. Stringent environmental regulations across all countries have increased the cost of developing new products and resulted in their delayed launch. This has been a strong barrier for new market players to utilize the opportunities to enter this market

Opportunity: Manufacturing adjuvant products for cost-effectiveness

The cost of adjuvants fluctuates and depends mainly on the prices of petroleum and vegetable oil that are used for agricultural adjuvant production. As the application costs of different single-purpose adjuvants during pesticide application prove to be expensive for growers, applicators are looking for adjuvants that are simple to use and multifunctional. The increased downstream cost, high foam formation during production, and low productivity have resulted in many R&D activities. Many new developments have been the area of focus for researchers; these include reducing the raw material costs, increasing the production yield, and developing new techniques to lower the foam formation.

Challenge: Impact on the production cost of farmers

The adoption of adjuvants further adds to the costs of seed and pesticides used for crop cultivation. Even though the adoption of adjuvants reduces the application cycles of pesticides, the cost of adjuvants could considerably affect the farm production cost to an extent. The cost again would depend on the stage at which the adjuvants are utilized, either as in-formulation or tank-mix adjuvants. The farmers’ profit margins get reduced due to the additional cost of adjuvants. However, with the increasing need to undertake sustainable measures to control pesticide drift and avoid creating environmental risks, farmers would adopt these adjuvants, which would, in turn, turn out to be cost burden, especially in developing countries.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1240

Asia Pacific comprises of developing countries with vast agricultural lands; the per capita income of the region depends on agricultural activities. Agricultural technologies are widely accepted and practiced in this region. In Asia Pacific, the total area under agriculture is shrinking due to the high rate of industrialization and urbanization. As a result, farmers opt for practices such as the use of chemical pesticides, which help to increase the yield or productivity of crops.

Key players in this market include Corteva Inc. (US), and Solvay (Belgium). These major players in this market are focusing on increasing their presence through expansions & investments, mergers & acquisitions, partnerships, joint ventures, and agreements. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities along with strong distribution networks across these regions.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Agricultural Adjuvants Market Drivers, Restraints, Opportunities & Challenges here

News-ID: 2463025 • Views:

More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analysis by 2028
Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624 These fertilizers are prized for their ability
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% from 2024 to 2029
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%. Download PDF Brochure:
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are